Mater Cars for Cancer Draw 132: $507K Package, 13 January Close

Mater Cars for Cancer Draw 132: $507K Prestige Vehicle Package Closes 13 January 2027

Draw 132 of Mater Cars for Cancer offers a $507k prestige vehicle prize package for $20 per ticket. Tickets close on 13 January 2027, giving you less than three months to enter this ACNC-registered charity lottery that funds cancer research at Mater Research in Queensland.

ACNC-registered charity lottery. Must be 18+. See ACNC Register for full charity details.

About Mater Cars for Cancer

Mater Cars for Cancer is an ACNC-registered charity (ABN 96 723 184 640) that funds cancer research at Mater Research in Queensland. Every ticket sold for Mater Cars for Cancer Draw 132 contributes directly to scientific research aimed at improving cancer treatments and patient outcomes. The charity operates prestige vehicle prize draws to raise funds for this mission.

Mater Research is one of Queensland's leading independent medical research institutes. The charity's lottery revenue supports cancer researchers working on clinical trials, drug development, and treatment innovation. By buying a ticket for this car lottery, you're funding scientists developing better therapies for patients across Queensland and beyond.

Car lottery draws like Draw 132 sit alongside other major fundraising initiatives in the Australian charity lottery space. If you're interested in exploring other high-value prize draws, consider checking out recent launches such as the Dream Home Draw 435, which offers a $14.7 million Palm Beach prize home and closes on 16 December 2026.

The Prize: $507K Prestige Vehicle Package

The top prize in Mater Cars for Cancer Draw 132 is a $507k prestige vehicle package. The exact vehicle make, model, trim level, and any additional inclusions (warranty, fuel, servicing, or accessories) should be confirmed on the operator's official draw page before you purchase.

Mater Cars for Cancer draws typically feature luxury vehicles valued at $150,000 or more. The $507k total package value may include the vehicle itself, optional cash components, or bundled benefits. Winners receive the prize free and clear — no taxes on the prize value itself, though investment returns from the prize are taxable (see Tax section below).

Prestige vehicle packages offer genuine appeal to car enthusiasts and those seeking a high-value asset. Unlike traditional cash prizes, a luxury vehicle combines practical use with investment potential. Many winners choose to keep their prize vehicles as personal transport or collectible assets.

The Odds: How Mater Cars for Cancer Draw 132 Compares

Charity car lotteries like Mater Cars for Cancer Draw 132 operate with a fixed ticket pool — a capped number of tickets sold. This is fundamentally different from state-run lotteries like Powerball or Saturday Lotto, which sell unlimited tickets and offer much worse odds.

Charity lottery odds depend on total tickets sold. Figures above are estimates unless sourced from the lottery operator.

Where the Money Goes

Mater Cars for Cancer is ACNC-registered, meaning its financial records are publicly available. You can verify the charity's revenue allocation and spending on the ACNC Register. The operator's annual financial statements show how much lottery revenue goes directly to cancer research programs at Mater Research versus administration and marketing costs.

Cancer affects one in two Australians in their lifetime, according to Cancer Council Australia. Mater Research uses lottery funding to accelerate clinical trials and develop new treatments. By purchasing a ticket for this car lottery, you're supporting scientists working directly on outcomes that affect thousands of Australians.

Buy tickets

Tax Treatment of Lottery Winnings

• Lottery winnings are not assessable income — the ATO does not tax the win itself.
• Interest and investment returns earned from winnings are taxable in the year earned.
• Capital gains tax applies if you invest winnings in shares or property and sell later at a profit.
• The operator pays stamp duty and transfer costs on prize vehicles; you own the vehicle free and clear.

Get advice from a registered accountant for your specific situation. See the ATO's guide on prizes and awards for official tax treatment.

Frequently Asked Questions

Is Mater Cars for Cancer a legitimate registered charity?

Yes. Mater Cars for Cancer is ACNC-registered (ABN 96 723 184 640). You can verify its charity status and financial records on the ACNC Register. All ACNC-registered charities are subject to regular audits and public accountability requirements.

What are the real odds of winning Mater Cars for Cancer Draw 132?

Your odds depend on how many tickets are sold before the draw closes on 13 January 2027. Charity car lotteries operate with a fixed ticket pool, so odds improve as fewer tickets are sold. Ask the operator for the current ticket pool size to calculate your exact odds. Charity lotteries typically offer much better odds than state-run lotteries like Powerball.

What happens if I win — do I have to keep the vehicle?

No. You own the prize vehicle outright and can sell it, trade it in, or keep it. The operator handles all transfer of ownership and registration. You are under no obligation to keep the vehicle if you prefer to sell it and use the proceeds.

Can I buy a Mater Cars for Cancer ticket if I live outside Queensland?

— check the operator's official page for state-by-state eligibility. Most Australian charity lotteries allow residents of all states to purchase tickets online, but some have restrictions. Confirm before you buy.

Is a Mater Cars for Cancer ticket tax-deductible?

No. Lottery tickets are not tax-deductible donations. The money you spend on a ticket is a purchase, not a charitable gift. However, the ticket price itself is not subject to GST, and any winnings are not taxable as income. If you want to make a direct tax-deductible donation to Mater Research, contact the charity separately.

What does Mater Cars for Cancer actually fund?

Lottery revenue funds cancer research programs at Mater Research in Queensland. This includes clinical trials, drug development, and treatment innovation. Mater Research is an independent medical research institute affiliated with Mater Hospitals. Specific program allocations are detailed in the charity's annual ACNC financial statements, available on the ACNC Register.

Tickets close 13 January 2027. Must be 18+ to enter. Win A Home is an independent directory.